about
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisMultispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm.Disease-modifying therapies in relapsing-remitting multiple sclerosis.Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.Clinical uses of intravenous immunoglobulin.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Intravenous immunoglobulins for multiple sclerosis
@ast
Intravenous immunoglobulins for multiple sclerosis
@en
Intravenous immunoglobulins for multiple sclerosis
@en-gb
Intravenous immunoglobulins for multiple sclerosis
@nl
type
label
Intravenous immunoglobulins for multiple sclerosis
@ast
Intravenous immunoglobulins for multiple sclerosis
@en
Intravenous immunoglobulins for multiple sclerosis
@en-gb
Intravenous immunoglobulins for multiple sclerosis
@nl
prefLabel
Intravenous immunoglobulins for multiple sclerosis
@ast
Intravenous immunoglobulins for multiple sclerosis
@en
Intravenous immunoglobulins for multiple sclerosis
@en-gb
Intravenous immunoglobulins for multiple sclerosis
@nl
P2093
P2860
P1476
Intravenous immunoglobulins for multiple sclerosis
@en
P2093
Gavin V McDonnell
Raeburn B Forbes
P2860
P356
10.1002/14651858.CD002936
P577
2003-07-21T00:00:00Z